Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NAD+

Boosting astrocytic NAD+ against tauopathy

Nicotinamide adenine dinucleotide (NAD+) decline is a molecular characteristic of aging and age-associated neurodegenerative diseases. Lee and colleagues uncover an astrocyte-specific regulatory axis directed by the circadian clock component REV-ERBα, and provide proof-of-concept evidence that targeting this pathway alleviates tauopathy in mouse models.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The REV-ERBα–NFIL3–CD38 axis regulates astrocytic NAD+ in tauopathy.

References

  1. Xie, N. et al. Signal Transduct. Target. Ther. 5, 227 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li, C. & Wu, L. E. Mech. Ageing Dev. 198, 111545 (2021).

    Article  CAS  PubMed  Google Scholar 

  3. Lee, J. et al. Nat. Aging https://doi.org/10.1038/s43587-025-00950-x (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Takahashi, J. S. Nat. Rev. Genet. 18, 164–179 (2017).

    Article  CAS  PubMed  Google Scholar 

  5. Asher, G. & Schibler, U. Cell Metab. 13, 125–137 (2011).

    Article  CAS  PubMed  Google Scholar 

  6. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. & Sassone-Corsi, P. Science 324, 654–657 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dierickx, P. et al. Nat. Cardiovasc. Res. 1, 45–58 (2022).

    Article  PubMed  Google Scholar 

  8. Lee, J. et al. Aging Cell 19, e13078 (2020).

    Article  CAS  PubMed  Google Scholar 

  9. Lee, J. et al. Nat. Commun. 14, 5197 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kojetin, D. J. & Burris, T. P. Nat. Rev. Drug Discov. 13, 197–216 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen, Z., Yoo, S. H. & Takahashi, J. S. Annu. Rev. Pharmacol. Toxicol. 58, 231–252 (2018).

    Article  CAS  PubMed  Google Scholar 

  12. Kim, E., Yoo, S. H. & Chen, Z. F1000Res. 11, 1236 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang, Y. et al. J. Neurosci. 34, 11929–11947 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. Proc. Natl Acad. Sci. USA 111, 16219–16224 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Holth, J. K. et al. Science 363, 880–884 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Research in the Z.C. and S.-H.Y. laboratories is in part supported by the National Institute on Aging (NIA, R01AG089967 and R01AG065984 to Z.C.) and the National Institute of Neurological Disorders and Stroke (NINDS, R01NS136677 to S.-H.Y.).

Author information

Authors and Affiliations

Authors

Contributions

Z.C. and S.-H.Y. jointly conceptualized the outline. Z.C. drafted the initial text. S.-H.Y. provided key conceptual input and drafted the figure. Z.C. and S.-H.Y. revised the complete draft and approved the submission.

Corresponding authors

Correspondence to Zheng Chen or Seung-Hee Yoo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Z., Yoo, SH. Boosting astrocytic NAD+ against tauopathy. Nat Aging 5, 1939–1941 (2025). https://doi.org/10.1038/s43587-025-00979-y

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43587-025-00979-y

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing